Cano Health Inc Receivables Turnover Ratio (CANO), from the first quarter 2024 to the first quarter 2023 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Cano Health Inc   (CANO)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Cano Health Inc Accounts Receivables Turnover Ratio from the first quarter 2024 to the first quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Cano Health Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2024 to a ratio of 36.41, above the company average. This is a clear sign of healthy business climate in the Healthcare Facilities industry and improving liquidity at their respective customers, during the first quarter 2024. Average receivable collection period, for the Cano Health Inc in Mar 31 2024 quarter, has decreased to 10 days, compared to 15 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 5 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from 91 to 112.

What is Receivable Turnover Ratio?
What is Cano Health Inc Selling?


What is Receivable Turnover Ratio?





CANO Receivables Turnover Ratio (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Y / Y Receivable Change -77.62 % -67.58 % -56.69 % -46.68 % 26.34 %
Y / Y Revenue Change -21.05 % 5.27 % 18.5 % 11.22 % 23.08 %
Receivable Turnover Ratio (TTM) 36.41 24.48 18.5 15.17 13.2
CANO's Total Ranking # 112 # 91 # 256 # 742 # 783
Accounts Receivable average collection period days 10 15 20 24 28
Seq. Receivable Change -28.47 % -13.37 % -18.35 % -55.76 % 3.6 %
Seq. Revenue Change -4.41 % -9.14 % 2.78 % -11.55 % 27.45 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 1
Healthcare Sector # 6
Overall Market # 112

Receivable Turnover Ratio Statistics
High Average Low
2.37 1.32 0.35
(Mar 31 2024)   (Mar 31 2022)






Financial Statements
Cano Health Inc 's Accounts Receivable $ 54 Millions Visit CANO's Balance sheet
Cano Health Inc 's Sales TTM $ 2,955 Millions Visit CANO's Income Statement
Sources of CANO's Revenues Visit CANO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CANO's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CANO's Growth Rates CANO's Roa CANO's Inventory Turnover Ratio CANO's Dividend Comparisons
CANO's Profitability Ratios CANO's Roi CANO's Asset Turnover Ratio CANO's Dividend Growth
CANO's Valuation Ratios CANO's Roe CANO's Financial Strength Ratios CANO's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Receivable at quarter ending Mar 31 2024
Logicmark Inc  128.97 $ 9.731  Millions$ 0.075  Millions
Fonar Corporation  124.17 $ 102.718  Millions$ 0.827  Millions
Scynexis Inc   122.34 $ 140.384  Millions$ 1.148  Millions
Electromedical Technologies Inc   117.55 $ 1.260  Millions$ 0.011  Millions
Orthofix Medical Inc   102.50 $ 759.311  Millions$ 7.408  Millions
Stoke Therapeutics Inc   102.20 $ 7.844  Millions$ 0.077  Millions
Lifevantage Corp  92.45 $ 204.649  Millions$ 2.214  Millions
Aclaris Therapeutics Inc   85.96 $ 31.119  Millions$ 0.362  Millions
Airsculpt Technologies Inc   85.94 $ 197.724  Millions$ 2.301  Millions
Lipocine Inc   84.79 $ 4.613  Millions$ 0.054  Millions
Zeo Scientifix Inc   84.50 $ 4.928  Millions$ 0.058  Millions
Takeda Pharmaceutical Company Limited  83.25 $ 29,166.692  Millions$ 350.335  Millions
Agape Atp Corporation  82.24 $ 1.369  Millions$ 0.017  Millions
Lucid Diagnostics Inc   79.55 $ 2.983  Millions$ 0.038  Millions
Longduoduo Co Ltd  77.88 $ 8.777  Millions$ 0.113  Millions
Pavmed Inc   67.75 $ 3.472  Millions$ 0.051  Millions
Ontrak Inc   65.04 $ 11.951  Millions$ 0.184  Millions
Brookdale Senior Living Inc   62.86 $ 3,045.397  Millions$ 48.446  Millions
Vbi Vaccines Inc  57.12 $ 9.411  Millions$ 0.165  Millions
Janux Therapeutics Inc   56.16 $ 7.287  Millions$ 0.130  Millions
Nature s Sunshine Products inc   44.22 $ 447.471  Millions$ 10.120  Millions
Nektar Therapeutics  43.14 $ 90.167  Millions$ 2.090  Millions
Renalytix Plc  43.00 $ 5.106  Millions$ 0.119  Millions
Dih Holding Us Inc   40.01 $ 108.887  Millions$ 2.721  Millions
Marpai Inc  39.39 $ 34.672  Millions$ 0.880  Millions
Vivos Therapeutics Inc   38.54 $ 12.351  Millions$ 0.321  Millions
Spero Therapeutics Inc   38.14 $ 110.979  Millions$ 2.910  Millions
Cano Health Inc   36.41 $ 2,955.274  Millions$ 81.171  Millions
Electrocore Inc   35.44 $ 17.889  Millions$ 0.505  Millions
Lifemd Inc   34.57 $ 161.635  Millions$ 4.675  Millions

Date modified: 2026-08-29T17:45:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.